为贯彻落实党的二十大报告中关于“强化食品药品安全监管”“促进中医药传承创新发展”的战略部署，近期，国家药监局组织召开加强中药全链条监管专题会议，研判分析当前中药质量安全监管和中药产业高质量发展面临的新形势和新任务，对现阶段中药监管工作进行了安排部署。
中(zhong)药(yao)(yao)(yao)监(jian)(jian)管(guan)各(ge)相关司局(ju)和(he)直(zhi)属单位围(wei)绕“进(jin)一步加强中(zhong)药(yao)(yao)(yao)安全监(jian)(jian)管(guan)，促(cu)(cu)进(jin)中(zhong)药(yao)(yao)(yao)传承创新发展”进(jin)行研究，并征集了各(ge)省药(yao)(yao)(yao)监(jian)(jian)局(ju)对促(cu)(cu)进(jin)中(zhong)药(yao)(yao)(yao)传承创新发展的监(jian)(jian)管(guan)实践经验和(he)建议，凝炼提出一系列政策(ce)措(cuo)施。这些政策(ce)措(cuo)施重点涵(han)盖强化(hua)(hua)中(zhong)药(yao)(yao)(yao)材质量(liang)管(guan)理、提升(sheng)中(zhong)药(yao)(yao)(yao)饮片监(jian)(jian)管(guan)效能(neng)、优化(hua)(hua)医疗机构中(zhong)药(yao)(yao)(yao)制(zhi)剂(ji)管(guan)理、科学管(guan)理中(zhong)药(yao)(yao)(yao)标(biao)准(zhun)、创新完(wan)善中(zhong)药(yao)(yao)(yao)审评审批机制(zhi)、重视中(zhong)药(yao)(yao)(yao)上市后(hou)评价(jia)、加强中(zhong)药(yao)(yao)(yao)质量(liang)安全监(jian)(jian)管(guan)、创建中(zhong)药(yao)(yao)(yao)监(jian)(jian)管(guan)科学体(ti)系、深(shen)化(hua)(hua)中(zhong)药(yao)(yao)(yao)监(jian)(jian)管(guan)国(guo)际合作、夯实中(zhong)药(yao)(yao)(yao)监(jian)(jian)管(guan)各(ge)项保(bao)障措(cuo)施等方面。
下一(yi)步，国家药(yao)(yao)(yao)监(jian)局将坚(jian)持以习(xi)近(jin)平新时代(dai)(dai)中(zhong)(zhong)(zhong)国特(te)色(se)社会主义(yi)思想为指(zhi)导，全(quan)面落实(shi)“四个最严”要求，持续深(shen)化中(zhong)(zhong)(zhong)药(yao)(yao)(yao)审评审批制度改革，强化中(zhong)(zhong)(zhong)药(yao)(yao)(yao)全(quan)产(chan)业链质量监(jian)管，推动新冠肺炎疫情等突发公(gong)共(gong)卫生事(shi)件中(zhong)(zhong)(zhong)药(yao)(yao)(yao)监(jian)管科(ke)学(xue)关(guan)键技术(shu)攻关(guan)，纵深(shen)推进中(zhong)(zhong)(zhong)国式现代(dai)(dai)化药(yao)(yao)(yao)品监(jian)管实(shi)践(jian)和具有中(zhong)(zhong)(zhong)国特(te)色(se)的(de)中(zhong)(zhong)(zhong)药(yao)(yao)(yao)监(jian)管科(ke)学(xue)体(ti)系(xi)建(jian)设。
